Urolithin A Improves Heart Function in Animal Models of Heart Failure
ScienceDaily Offbeat ·
·
1 min read ·
Humanities
Read research and analysis on Urolithin A Improves Heart Function in Animal Models of Heart Failure published by ICANEWS, a global research journal for emerging researchers.
Key Takeaways
Urolithin A improved measures of heart function by up to 80% in animal models of a difficult-to-treat form of heart failure.
Urolithin A helped stiff heart tissue relax.
Urolithin A reduced scarring and abnormal enlargement in heart tissue.
Urolithin A improved relaxation in engineered human heart tissue.
Why This Matters
The findings suggest a potential role for urolithin A in addressing difficult-to-treat forms of heart failure by improving cardiac relaxation, reducing scarring, and mitigating enlargement, which could be significant for heart health.
Overview
Research indicates that urolithin A, a compound metabolized by the body from certain foods including pomegranates, walnuts, and some berries, improved heart function in animal models. The improvements observed reached up to 80% in models representing a form of heart failure that is challenging to treat. Beyond animal models, urolithin A also enhanced relaxation in engineered human heart tissue.
Findings
Urolithin A improved measures of heart function by up to 80% in animal models.
The heart failure in these animal models was described as a difficult-to-treat form.
The compound assisted stiff heart tissue in relaxing.
Urolithin A reduced cardiac scarring.
Abnormal enlargement of the heart was mitigated by the compound.
In engineered human heart tissue, urolithin A also improved relaxation.